GO
Loading...

Enter multiple symbols separated by commas

Search results for "GSK"

REFINE RESULTS

SEARCH RESULTS

About 56 results. Sort By: Date | Relevance
This historic biotech hub faces threat from US

As Vienna's life science companies grow, the very sector the city has worked so hard to build risks falling behind rivals across in the U.S.
Source: CNBC.com | By: Arjun Kharpal
UPDATE 1-U.S. bird flu causes egg shortage, emergency measures

CHICAGO/ NEW YORK, May 22- As a virulent avian influenza outbreak continues to spread across the Midwestern United States, some egg-dependent companies are contemplating drastic steps- importing eggs from overseas or looking to egg alternatives. A spokeswoman for Archer Daniels Midland Co said that as egg supplies tighten and prices rise, the food processing...
Source: Reuters | By: P.J. Huffstutter and Bill Berkrot
U.S. bird flu causing egg squeeze, emergency measures

CHICAGO and NEW YORK, May 22- As a virulent avian influenza outbreak continues to spread across the Midwestern United States, some egg-dependent companies are contemplating drastic steps: importing eggs from overseas or looking to egg alternatives. "Canada is short on eggs and has been buying heavily from the U.S. for the last several years," said Rick Brown, a...
Source: Reuters | By: P.J. Huffstutter and Bill Berkrot
Cramer: Mergers that could unlock riches for you

Jim Cramer considers this group to be the single best out there, and it's ready to pull off some big deals. Time to call your broker.
Source: CNBC.com | By: Abigail Stevenson
UPDATE 2-J&J to submit at least 10 new drugs for approval by 2019

May 20- U.S. healthcare conglomerate Johnson& Johnson said on Wednesday it expects to submit more than 10 new medicines with annual revenue potential of at least $1 billion each to regulators by 2019, and is testing dozens of new uses for existing medicines. J&J said it would file for approval of daratumumab for the blood cancer multiple myeloma in the United...
Source: Reuters | By: Bill Berkrot and Caroline Humer
UPDATE 1-J&J to submit at least 10 medicines for approval by 2019

NEW YORK, May 20- U.S. healthcare conglomerate Johnson& Johnson said on Wednesday it expects to submit more than 10 new medicines with annual revenue potential of at least $1 billion each to regulators by 2019, and is testing dozens of new uses for existing medicines. J&J said it would file for approval of the experimental drug daratumumab for the blood cancer...
Source: Reuters | By: Bill Berkrot and Caroline Humer
India ignored warnings on foreign investor tax row -sources

*Tax officials say warned Finance Ministry since September. *Row with investors caused sell-off in India stocks, bonds. MUMBAI, May 19- India's Finance Ministry could have sidestepped a damaging multibillion-dollar tax row with foreign investors if it had acted on regular warning letters that officials had been sending since as long ago as September.
Source: Reuters | By: Himank Sharma and Rafael Nam
Cramer: Next week jam-packed with retail earnings  

Mad Money host Jim Cramer looks ahead to market moving events, earnings and data set to happen next week, including quarterly numbers by Urban Outfitters, Target and Salesforce.
Source: CNBC.com
Four trades to go before the closing bell

The "Halftime Report" traders delivered their trades for the second half of the day.
Source: CNBC.com | By: Bree Kelly
The semiconductor trade: 4 stocks to watch

"Fast Money" traders looked at stocks that could pop in the battered semiconductor sector after Applied Materials' earnings beat.
Source: CNBC.com | By: Jacob Pramuk